Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
Globe Newswire•17/08/2026•08:52 ET
0
Whiz Insights
The Patent Claims are for the Intended Commercial Formulation of ART27.13
Expected to Extend Patent Protection for ART27.13 through 2041
Get started
Create a free account to read the full story.